Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Disruption of BMI1 dynamic balance weakens immunotherapy efficacy in HCC

ABSTRACT: Low reactivity and short duration of tumor-infiltrated T cells limit HCC immunotherapy efficacy. The proliferative ability of T cells maybe accounts for these deficiencies. This study aimed to define the key factor regulating TILs proliferation in HCC microenvironment.

ORGANISM(S): Homo Sapiens

SUBMITTER: Xuyong Wei

PROVIDER: PXD039456 | iProX | Sat Jan 14 00:00:00 GMT 2023

REPOSITORIES: iProX

ACCESS DATA

Json Xml

Similar Datasets

Disruption of BMI1 dynamic balance blunts immunotherapy efficacy in HCC

Project description:Disruption of BMI1 dynamic balance blunts immunotherapy efficacy in HCC

| PRJNA911277 | ENA

Disruption of BMI1 dynamic balance blunts immunotherapy efficacy in HCC

Project description:To investigated how BMI1 inhibitor (PTC) affected the function of primary T cells, we treated Tcells with PTC. We then performed gene expression profiling analysis using data obtained from RNA-seq of peritoneal macrophages with PTC 209.

2024-05-29 | GSE220751 | GEO

BMI1 dynamic balance destroy blunts immunotherapy efficacy in HCC

Project description:BMI1 dynamic balance destroy blunts immunotherapy efficacy in HCC

| PRJNA913003 | ENA

The pause-initiation limit restricts transcription activation in human cells

Project description:Eukaryotic gene transcription is often controlled at the level of RNA polymerase II (Pol II) pausing in the promoter-proximal region. Pausing Pol II limits the frequency of transcription initiation (‘pause-initiation limit’), predicting that the pause duration must be decreased for transcriptional activation. To test this prediction, we conducted a genome-wide kinetic analysis of the heat shock response in human cells. We show that the pause-initiation limit restricts transcriptional activation at most genes. Gene activation generally requires the activity of the P-TEFb kinase CDK9, which decreases the duration of Pol II pausing and thereby enables an increase in the productive initiation frequency. The transcription of enhancer elements is generally not pause-limited and can be activated without CDK9 activity. Our results define the kinetics of Pol II transcriptional regulation in human cells at all gene classes during a natural transcription response.

2019-07-10 | GSE123980 | GEO

3-D culture cell lines mimic tumor in hepatocellular carcinoma

Project description:Hepatocellular carcinoma (HCC) is one of the main subtypes of primary liver cancer, which accounts for 75-85% of all cases [1]. Despite increasing availability of treatments for liver cancer, HCC clinical trials are not promising since most HCC patients are in an advanced stage of HCC at the time of diagnosis. Additionally, highly metastatic and recurrent phenotype aggravate poor prognosis of liver cancer [2]. Therefore, there is an urgent need to explore the underlying molecular mechanism in HCC progression.

2023-09-18 | PXD036831 | JPOST Repository

Provoking the Immunotherapy Efficacy of Renal Medullary Carcinoma [RNA-seq I]

Project description:Renal medullary carcinoma (RMC) predominantly afflicts young individuals of African descent harboring sickle hemoglobinopathies such as sickle cell disease (SCD) or sickle cell anemia (SCA). RMC is refractory to targeted and immune therapy strategies used for other renal cell carcinomas. We have demonstrated that RMC is resistant to immune checkpoint inhibition despite harboring an inflamed tumor immune microenvironment. Hence, novel therapeutic strategies are urgently needed to reverse this resistance. We discovered that CD8+ T cells under SCD condition exhibit altered genomic architecture and ferroptosis, which significantly impairs the anti-tumor immunity of effector T cells. These observations may underscore a fundamental mechanism behind the distinct resistance of RMC resistance to immune checkpoint therapies. By leveraging the use of both mouse SCD model and humanized mice phenotypically representing SCD/SCA, as well as primary CD8+ T cells isolated from patients with SCA, we identified that the SLC7A11 gene is transcriptionally downregulated in the CD8+ T cells of SCA donors via genomic architecture alteration. The reduced expression of SLC7A11 partially accounts for the ferroptosis observed in the CD8+ T cells of SCD disease, via impairing the cystine transportation and synthesis of Glutathione (GSH). Our findings also demonstrated that treatment using a hydrogen sulfide slow-releasing donor restored the expression of SLC7A11, antagonized the ferroptosis of CD8+ T cells under SCD/SDA condition and restored anti-tumor immunity in vivo. Hence, our research findings provide novel mechanistic insights into SCD and RMC and pave the way to develop innovative therapeutic strategies to sensitize RMC to immune therapies.

2025-07-02 | GSE231386 | GEO

Provoking the Immunotherapy Efficacy of Renal Medullary Carcinoma [RNA-seq II]

2025-07-02 | GSE240827 | GEO

MYC-HCC treated with immunotherapy

Project description:MYC-HCC treated with immunotherapy

| PRJNA888064 | ENA

Mishra2018 - enhancing sorafenib efficacy by co-target identification through quantitive modelling approach

Project description:Kinetic model of GSHnet of different HCC etiological conditions.

2019-08-07 | MODEL1808060001 | BioModels

Knockdown of the long noncoding RNA PURPL induces apoptosis and sensitizes liver cancer cells to doxorubicin

Project description:Liver cancer was the fourth leading cause of cancer-related deaths worldwide in 2018, of which Hepatocellular carcinoma accounts for 75-85% of all liver cancers and is therefore the most common type of liver cancer. In this study, total RNA were extracted from sections of formalin-fixed paraffin embedded (FFPE) archival human liver biopsies from 24 patients, including ten HCV-associated HCC (HCV-HCC), ten virus-unrelated HCC (VU-HCC) and four normal liver patients. By comparing the expression profiles of HCV-HCC and VU-HCC to that of the normal liver biopsies respectively, 18 lncRNAs were identified to be differentially expressed.

2022-11-21 | GSE185700 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data